SCHEMBL758765

SCHEMBL758765

O=C1N=CC2(CCNCC2)N1

nearest known ligand 0.35

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
NEK2 P51955 1/20 0.35
SIGMAR1 Q99720 2/20 0.30
DRD2 P14416 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12473466 0.81 TSHR (0.36)
SCHEMBL9851649 0.65 NEK2 (0.33) NEK2
Hydrochloric Acid SCHEMBL2496395 0.62 NEK2 (0.35) NEK2SIGMAR1DRD2
SCHEMBL1630318 0.60 NEK2 (0.36) NEK2
SCHEMBL17113583 0.58 HSD17B10 (0.34) NEK2
SCHEMBL13282119 0.56 NEK2 (0.46) NEK2
SCHEMBL30893543 0.55
SCHEMBL1373550 0.55 OPRM1 (0.38) NEK2
SCHEMBL15416446 0.55 NEK2 (0.35) NEK2SIGMAR1DRD2
SCHEMBL10068052 0.53 NEK2 (0.38) NEK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1910364-B1 SPIROPIPERIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE MERCK SHARP & DOHME (US) 2012-03-21 EP claimed